HERAMED LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.018 AUD | -.--% |
|
+12.50% | -25.00% |
| May. 20 | HeraMED Appoints Auditor | MT |
| May. 13 | Transcript : HeraMED Limited - Special Call |
| Sales 2022 | 219K 329K | Sales 2023 | 403K 606K | Capitalization | 5.25M 7.89M |
|---|---|---|---|---|---|
| Net income 2022 | -4M -6.01M | Net income 2023 | -4M -6.01M | EV / Sales 2022 | 83.2 x |
| Net cash position 2022 | 2.46M 3.7M | Net cash position 2023 | 575K 864K | EV / Sales 2023 | 11.6 x |
| P/E ratio 2022 |
-3.74
x | P/E ratio 2023 |
-0.95
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.04% |
More Fundamentals
* Assessed data
More news
Latest transcript on HeraMED Limited
More recommendations
More news
| 1 week | +12.50% | ||
| 1 month | +2.86% | ||
| 3 months | -10.00% | ||
| 6 months | -55.00% | ||
| Current year | -25.00% |
1 week
0.02
0.02
1 month
0.010.02
Current year
0.010.03
1 year
0.010.09
3 years
0.010.34
5 years
0.010.34
10 years
0.010.34
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 22-06-30 | |
Michal Yardeny
ADM | Chief Administrative Officer | - | - |
Nir Pearl
COO | Chief Operating Officer | - | 22-09-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Hinton
BRD | Director/Board Member | 60 | 18-08-20 |
Timothy Chapman
CHM | Chairman | - | Mar. 10 |
| Chief Executive Officer | - | 22-06-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 0.018 | -.--% | 1,200,000 |
| 24-05-30 | 0.018 | +5.88% | 935,770 |
| 24-05-29 | 0.017 | -5.56% | 280,000 |
| 24-05-28 | 0.018 | -.--% | 1,431,580 |
| 24-05-27 | 0.018 | +12.50% | 349,831 |
Delayed Quote Australian S.E., May 30, 2024 at 08:13 pm EDT
More quotes
Hera Med Ltd is an Israel-based company that develops pregnancy monitoring solutions for home and professional use. It offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetusâ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The Company also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -25.00% | 4.7M | |
| -17.59% | 2.74B | |
| +2.53% | 187M | |
| -16.53% | 80.66M |
- Stock Market
- Equities
- HMD Stock
